AIPTO Techbio GmbH
Patient-avatar platform using tumor explants and organoids to faithfully replicate in vivo tumor biology.
Generative AI powered by single-cell RNA-seq data to accelerate drug discovery and enable precision medicine for brain cancer patients.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A